UNC-Chapel Hill researchers and industry scientists are working side by side in the same lab on Carolina’s campus to find a cure for HIV — and they’re getting closer. ViiV Healthcare and Carolina have recently announced that they have signed a second five-year, $20 million contract to continue their groundbreaking research to find a cure.
The new complex will enable further advances in its world-leading traumatic brain injury research.
Overcoming HIV latency is a major step toward creating a cure for HIV. For the first time, scientists at Carolina, Emory University and Qura Therapeutics – a partnership between Carolina and ViiV Healthcare – have found a new approach that can expose latent HIV.
UNC-Chapel Hill researchers examined how negative media coverage of the HPV vaccine impacted vaccination rates in Denmark to better understand the damage misinformation causes.